Lab to £30m+ in revenue and a $310m exit | Eric Mayes | CEO of Endomag

Lab to Market Leadership with Chris Reichhelm

In this episode of Lab to Market Leadership, Chris Reichhelm sits down with Eric Mayes, CEO of Endomag, to explore the rare journey of building a medtech startup from the ground up. Eric discusses the strategies that propelled Endomag to the forefront of cancer detection technology and culminated in a $310 million acquisition by Hologic. Perfect for medtech entrepreneurs and all Deep Tech innovators, this episode uncovers the milestones, challenges, and insights on transforming groundbreaking tech into market success.

Let us know what you think...

Learn more about Lab to Market Leadership: https://www.deeptechleaders.com
Follow us on LinkedIn: https://www.linkedin.com/company/deeptechleaders
Podcast Production: Beauxhaus

บท

1. Making a Difference (00:00:00)

2. Welcome to the Lab to Market Leadership Podcast (00:01:24)

3. Introducing Eric Mayes and Endomag (00:02:07)

4. Eric Mayes' Unique Journey and Experience (00:02:41)

5. Endomag's Path to Profitability and Acquisition (00:05:14)

6. The Early Days of Endomag (00:08:14)

7. Endomag's Founding and Initial Challenges (00:09:32)

8. Eric Mayes' Background and Skills (00:15:46)

9. Navigating Regulatory Challenges (00:23:23)

10. Overcoming Existential Crises (00:29:36)

11. Building a Strong Executive Team (00:35:32)

12. Navigating Early Revenue Challenges (00:37:04)

13. Developing a Transformative Product (00:38:22)

14. Customer-Centric Innovation (00:39:17)

15. Building a Unified Team (00:40:46)

16. Cultivating a Strong Company Culture (00:42:23)

17. Strategic Hiring Practices (00:47:24)

18. Overcoming Fundraising Hurdles (00:48:40)

19. Expanding into the U.S. Market (01:02:01)

20. The Impact of Direct Sales (01:06:13)

21. Reflections and Future Plans (01:07:44)

22. Conclusion and Final Thoughts (01:14:59)